Open access
514
Views
3
CrossRef citations to date
0
Altmetric
Andrology/Sexual Medicine
Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive reviewFootnotePeer review under responsibility of Arab Association of Urology.
Albert HaddadLilly Research Laboratories, Eli Lilly and Company, Dubai, United Arab EmiratesCorrespondence[email protected]
, Michel JabbourDivision of Urology, Saint Georges Hospital, Balamand University, Achrafieh, Beirut, Lebanon
& Muhammad BulbulDivision of Urology, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon
Pages 155-161
|
Received 12 Nov 2014, Accepted 10 Jun 2015, Published online: 05 Apr 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.